TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15673180

Group type: EXPERIMENTAL
Intervention: Symmetrized faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smooth motion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two control motions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory tasks with symmetric orientation effects
Number of subjects: 0
Study: 11958389

Group type: EXPERIMENTAL
Intervention: Recombinant human bFGF administered weekly by intravenous infusions of 2 microg/kg for 6 weeks (total dose 12 microg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9042989

Group type: EXPERIMENTAL
Intervention: Lactulose 20 g t.d.s. for 15 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lactose 20 g t.d.s. as placebo
Number of subjects: 14
Study: 7706699

Group type: EXPERIMENTAL
Intervention: 50mg losartan
Number of subjects: 135

Group type: COMPARATOR
Intervention: 20mg lisinopril
Number of subjects: 135

Group type: COMPARATOR
Intervention: 25mg hydrochlorothiazide
Number of subjects: 135
Study: 3373408

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 79

Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 79
Study: 31365829

Group type: EXPERIMENTAL
Intervention: Nintedanib plus sildenafil
Number of subjects: 273

Group type: COMPARATOR
Intervention: Nintedanib alone
Number of subjects: 273
Study: 27834479

Group type: EXPERIMENTAL
Intervention: 26F resectoscope requiring cervical dilatation (group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 5-mm hysteroscope requiring vaginoscopic approach (group B)
Number of subjects: 80
Study: 25555797

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (54 μg per spray, mean total dose 734 μg, duration of use 3.5 h)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl
Number of subjects: 32
Study: 24740462

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 23132474

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg intravenously 1 hour prior to subarachnoid block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo) 2 ml intravenously 1 hour prior to subarachnoid block
Number of subjects: 80
Study: 18501499

Group type: EXPERIMENTAL
Intervention: Microsatellite analysis (MA) of voided-urine samples
Number of subjects: 228
Study: 17697450

Group type: EXPERIMENTAL
Intervention: OROS hydromorphone in the treatment of chronic low back pain (CLBP)
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: OROS hydromorphone in the treatment of pain associated with chronic osteoarthritis (OA)
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: Mapping algorithm developed in the MOS study
Number of subjects: 1736
Study: 15138569

Group type: EXPERIMENTAL
Intervention: 13‐cRA at a dose of 0.5 mg/kg per day per os
Number of subjects: 267

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267
Study: 14746165

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005%
Number of subjects: 71

Group type: COMPARATOR
Intervention: timolol-pilocarpine
Number of subjects: 71
Study: 9690954

Group type: EXPERIMENTAL
Intervention: Tucaresol 200 mg after overnight fast
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tucaresol 200 mg after ingestion of a standard breakfast
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tucaresol 200 mg in females
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tucaresol 200 mg in males
Number of subjects: 18
Study: 7659481

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (DTaP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-cell pertussis vaccine (DTP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-cell pertussis vaccine (WCL)
Number of subjects: 0
Study: 2568785

Group type: COMPARATOR
Intervention: Iotrolan 240 mg I/ml
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iotrolan 300 mg I/ml
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iohexol 240 mg I/ml
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iohexol 300 mg I/ml
Number of subjects: 100
Study: 409803

Group type: EXPERIMENTAL
Intervention: Clonazepam added to treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonazepam with phenobarbitone
Number of subjects: 0
Study: 31880966

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 plus bevacizumab 15 mg/kg
Number of subjects: 599

Group type: COMPARATOR
Intervention: Bevacizumab 15 mg/kg
Number of subjects: 599
Study: 30934284

Group type: EXPERIMENTAL
Intervention: Entropy-based randomization method for bipartite rating networks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Louvain community detection on the obtained network
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of the method to categorical bipartite networks
Number of subjects: 0
Study: 28981579

Group type: EXPERIMENTAL
Intervention: Group AWS-FOB (Pentax Airway Scope)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group OVA-FOB (Ovassapian airway)
Number of subjects: 90
Study: 25084742

Group type: EXPERIMENTAL
Intervention: Miconazole mucoadhesive buccal tablet (MBT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional oral amphotericin B suspensions
Number of subjects: 104
Study: 23535839

Group type: EXPERIMENTAL
Intervention: Four cycles of standard FEC (fluorouracil, epirubicin, cyclophosphamide) followed by four cycles of docetaxel
Number of subjects: 3596

Group type: COMPARATOR
Intervention: Eight cycles of anthracycline-based chemotherapy
Number of subjects: 3596
Study: 21707626

Group type: EXPERIMENTAL
Intervention: Gatekeeper Suicide-Awareness Program
Number of subjects: 195

Group type: COMPARATOR
Intervention: Regular monthly continuing education class (Control)
Number of subjects: 195
Study: 20303910

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 56
Study: 16432076

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) with melphalan 140 mg/m2 plus total-body irradiation 12 Gy
Number of subjects: 516

Group type: COMPARATOR
Intervention: Standard-dose therapy (SDT) using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Standard-dose therapy (SDT)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) maintenance therapy
Number of subjects: 516

Group type: COMPARATOR
Intervention: No maintenance therapy
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Salvage autotransplantation after relapse on SDT
Number of subjects: 516

Group type: COMPARATOR
Intervention: Further standard-dose therapy (SDT) after relapse
Number of subjects: 516
Study: 15224704

Group type: EXPERIMENTAL
Intervention: Corticosteroids (group S)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Albendazole (group A)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Corticosteroids and Albendazole (group SA)
Number of subjects: 110
Study: 11513193

Group type: EXPERIMENTAL
Intervention: Recombinant interleukin-12 (rhIL-12) at a dose of 300 ng/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9640077

Group type: EXPERIMENTAL
Intervention: IDDM with albuminuria
Number of subjects: 34

Group type: COMPARATOR
Intervention: IDDM without microalbuminuria
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 34
Study: 8489988

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% plus epinephrine at 650 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lidocaine 1% plus epinephrine at 500 mg
Number of subjects: 45
Study: 3488982

Group type: EXPERIMENTAL
Intervention: External electrostimulation (EES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study: 29450877

Group type: EXPERIMENTAL
Intervention: Preoperative paracetamol (IV infusion of paracetamol 15 mg kg‐1 1 h before surgery)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Postoperative paracetamol (IV infusion of paracetamol 15 mg kg‐1 in recovery room)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (IV infusion of saline pre‐ and postoperatively)
Number of subjects: 96
Study: 26948991

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (target SBP < 140 mmHg)
Number of subjects: 2623

Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (target SBP < 180 mmHg)
Number of subjects: 2623
Study: 24357575

Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care for Adolescents (MTFC‐A)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 219
Study: 21899712

Group type: EXPERIMENTAL
Intervention: long‐course chemoradiotherapy (chRT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: short‐term radiotherapy (sRT)
Number of subjects: 83
Study: 16011564

Group type: EXPERIMENTAL
Intervention: Cooled filtered water with active promotion (W + P)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water only (W)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control school (C)
Number of subjects: 0
Study: 12572529

Group type: EXPERIMENTAL
Intervention: tolterodine L-tartrate (2 mg twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 9459246

Group type: EXPERIMENTAL
Intervention: Lidocaine plus 2 mL sodium bicarbonate 8.4%
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lidocaine hydrochloride
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lidocaine CO2
Number of subjects: 24
Study: 8590507

Group type: EXPERIMENTAL
Intervention: Clonidine 4 micrograms.kg‐1
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Diazepam 0.4 mg.kg‐1
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Clonidine 2 micrograms.kg‐1
Number of subjects: 140
Study: 2225951

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (2 mg every 2 hours for 6 hours)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Metaproterenol (15 mg every 2 hours for 6 hours)
Number of subjects: 46
Study: 24686

Group type: EXPERIMENTAL
Intervention: Antacid suspensions (liquid form)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Antacid chewing tablets
Number of subjects: 36
Study: 29895341

Group type: COMPARATOR
Intervention: Ear wick (n = 28)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ribbon gauze (n = 34)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Biodegradable synthetic polyurethane foam (n = 30)
Number of subjects: 92
Study: 28266242

Group type: EXPERIMENTAL
Intervention: Sertraline (135 mg daily)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 24136056

Group type: EXPERIMENTAL
Intervention: Midline posterior approach
Number of subjects: 50

Group type: COMPARATOR
Intervention: Paraspinal approach
Number of subjects: 50
Study: 23782513

Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 21126230

Group type: EXPERIMENTAL
Intervention: iPod™ lectures
Number of subjects: 35

Group type: COMPARATOR
Intervention: Classroom lectures without iPods™
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Frequent use of iPod™ before final exam
Number of subjects: 35
Study: 17999695

Group type: EXPERIMENTAL
Intervention: BellyBra
Number of subjects: 115

Group type: COMPARATOR
Intervention: tubigrip
Number of subjects: 115
Study: 16476843

Group type: EXPERIMENTAL
Intervention: Amlodipine+/−perindopril-based therapy
Number of subjects: 2199

Group type: COMPARATOR
Intervention: Atenolol+/−thiazide-based therapy
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Central pulse pressure
Number of subjects: 2199
Study: 12742836

Group type: EXPERIMENTAL
Intervention: 2 hours of daily patching combined with at least 1 hour per day of near visual activities
Number of subjects: 189

Group type: COMPARATOR
Intervention: 6 hours of daily patching combined with at least 1 hour per day of near visual activities
Number of subjects: 189
Study: 11075250

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 36

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 36
Study: 8603558

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) treatment with end-to-end anastomosis
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) treatment with side-to-side or end-to-side anastomosis
Number of subjects: 110

Group type: COMPARATOR
Intervention: End-to-end anastomosis
Number of subjects: 110

Group type: COMPARATOR
Intervention: No specific control intervention mentioned
Number of subjects: 110
Study: 1419473

Group type: EXPERIMENTAL
Intervention: Active treatment (1 mg perindoprilat in 30 ml) over 1 h
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Active treatment (1 mg perindoprilat in 30 ml) over 3 h
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Active treatment (1 mg perindoprilat in 30 ml) over 6 h
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline placebo (30 ml) over 3 h
Number of subjects: 8
Study: 3965336

Group type: EXPERIMENTAL
Intervention: Bicozamycin (500 mg four times a day for 3 weeks)
Number of subjects: 30
Study: 31615577

Group type: EXPERIMENTAL
Intervention: Initial online survey
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Interim online survey
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Face-to-face consensus meeting
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Top 10 questions
Number of subjects: 456
Study: 29716756

Group type: EXPERIMENTAL
Intervention: Functional imaging
Number of subjects: 1202
Study: 26580300

Group type: EXPERIMENTAL
Intervention: Alex stent (second-generation cobalt-chromium sirolimus-eluting stent)
Number of subjects: 424
Study: 25294214

Group type: EXPERIMENTAL
Intervention: Overfeeding with 140% of energy needs, with 5, 15, or 25% of energy from protein for 56 days
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overfeeding with 140% of energy needs
Number of subjects: 25
Study: 23227677

Group type: EXPERIMENTAL
Intervention: Acupuncture at Renying (ST 9), Hegu (LI 4), Taichong (LR 3), Quchi (LI 11), and Zusanli (ST 36) for 3 months, 5 days a week with 2 days off
Number of subjects: 70
Study: 20722847

Group type: EXPERIMENTAL
Intervention: Testosterone (5 mg/d)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 18388249

Group type: EXPERIMENTAL
Intervention: Aerobic cycle training (30 min at 60% of peak O2 uptake, 3 days/week for 8 weeks)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aerobic cycle training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Single bout of exercise
Number of subjects: 22
Study: 15970828

Group type: EXPERIMENTAL
Intervention: Extended-release oxybutynin (10 mg/d)
Number of subjects: 790

Group type: COMPARATOR
Intervention: Extended-release tolterodine (4 mg/d)
Number of subjects: 790
Study: 12452243

Group type: COMPARATOR
Intervention: Intravenous morphine 10 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg and lornoxicam 16 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg, lornoxicam 16 mg with 0.5% ropivacaine local skin infiltration before skin incision and 1% ropivacaine instillation before peritoneal incision
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg, lornoxicam 16 mg with 1% ropivacaine instillation after peritoneal closure and 0.5% ropivacaine local skin infiltration before skin closure
Number of subjects: 88
Study: 11563411

Group type: EXPERIMENTAL
Intervention: Standard regimen (5 days high dose 1,050 mg/m2/day followed by 14 days low dose 700 mg/m2/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Alternate regimen (two courses of high dose therapy separated by one week)
Number of subjects: 11
Study: 7580706

Group type: EXPERIMENTAL
Intervention: Low lipid standardised plasma vitamin E concentration (below median)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Decrement of 1 mumol/l of uncategorised unstandardised vitamin E concentration
Number of subjects: 944
Study: 2068533

Group type: EXPERIMENTAL
Intervention: Hypnotically induced emotional states (anger, depression, happiness)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hypnotically induced emotional states (happiness)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Before hypnosis
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Angry emotional state
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Depressed emotional state
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DOPA levels
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cortisol levels and catecholamine plasma levels
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Soluble interleukin-2 receptors
Number of subjects: 11
Study: 6117379

Group type: EXPERIMENTAL
Intervention: Oxprenolol SR (160-320 mg/day)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (identical tablets)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oxprenolol SR
Number of subjects: 6
Study: 31706662

Group type: EXPERIMENTAL
Intervention: Rapid changes in temperature (large decrease)
Number of subjects: 20558

Group type: EXPERIMENTAL
Intervention: Changes in atmospheric pressure
Number of subjects: 20558

Group type: EXPERIMENTAL
Intervention: Changes in relative humidity
Number of subjects: 20558
Study: 30452653

Group type: EXPERIMENTAL
Intervention: Prime (cooked to medium-rare and lower)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Prime (cooked to medium and higher)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Combined cooked moisture and fat percentages
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Increased marbling levels
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cooked residual moisture and fat percentages (combined)
Number of subjects: 5
Study: 27417906

Group type: EXPERIMENTAL
Intervention: Combined speech and gesture condition
Number of subjects: 11

Group type: COMPARATOR
Intervention: Gesture-only condition
Number of subjects: 11

Group type: COMPARATOR
Intervention: Speech-only condition
Number of subjects: 11
Study: 25425704

Group type: EXPERIMENTAL
Intervention: Respiratory care bundle implemented through NIC/Q 2005
Number of subjects: 1050
Study: 24227733

Group type: EXPERIMENTAL
Intervention: Auditory-evoked activity to pure tones of high, medium, and low frequencies in anophthalmic participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Auditory-evoked activity to pure tones of high, medium, and low frequencies in sighted controls
Number of subjects: 0
Study: 21366949

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study: 20039525

Group type: EXPERIMENTAL
Intervention: Web-based stigma education program (informative e-mail about stigma)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control group (no informative e-mail)
Number of subjects: 205
Study: 17267931

Group type: EXPERIMENTAL
Intervention: Increased support through six weekly visits by a trained advisor
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 271
Study: 15521874

Group type: EXPERIMENTAL
Intervention: 1-hour rest post-embryo transfer
Number of subjects: 0

Group type: COMPARATOR
Intervention: 24-hour rest post-embryo transfer
Number of subjects: 0
Study: 11885112

Group type: EXPERIMENTAL
Intervention: Second-generation anticonvulsants (felbamate, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine, topiramate, zonisamide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: First-generation anticonvulsants (phenobarbital, phenytoin, valproate)
Number of subjects: 0
Study: 9679794

Group type: EXPERIMENTAL
Intervention: Nurse-mediated cholesterol management (NURS)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Enhanced primary care (EPC)
Number of subjects: 156
Study: 7983283

Group type: EXPERIMENTAL
Intervention: Post-discharge geriatric home assessment by a gerontologic nurse practitioner (GNP)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Post-discharge geriatric home assessment by a GNP
Number of subjects: 152
Study: 2962925

Group type: EXPERIMENTAL
Intervention: FUdR
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Aphidicolin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Caffeine and Aphidicolin
Number of subjects: 8
Study: 30157103

Group type: EXPERIMENTAL
Intervention: Milk supplementation (20 g of protein, 2 servings daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Native whey supplementation (20 g of protein, 2 servings daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both interventions (Milk and Native whey)
Number of subjects: 40
Study: 29868868

Group type: EXPERIMENTAL
Intervention: Research‐Based and Developmentally Informed‐Parent home visiting program (REDI‐P)
Number of subjects: 200

Group type: COMPARATOR
Intervention: math home learning games in the mail
Number of subjects: 200
Study: 26919735

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 388
Study: 25419179

Group type: EXPERIMENTAL
Intervention: Intraoperative glucose-insulin-potassium infusion (GIK)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Intraoperative sliding-scale insulin boluses (BR)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: GLP-1 pre-treatment with liraglutide (LG)
Number of subjects: 315
Study: 23015652

Group type: EXPERIMENTAL
Intervention: Orchidopexy at 9 months
Number of subjects: 213

Group type: COMPARATOR
Intervention: Orchidopexy at 3 years
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Both ages (9 months and 3 years)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Hormone levels (LH, FSH, testosterone, inhibin B)
Number of subjects: 213
Study: 20568977

Group type: EXPERIMENTAL
Intervention: iodixanol 320 mgI/ml
Number of subjects: 100

Group type: COMPARATOR
Intervention: iomeprol 400 mgI/ml
Number of subjects: 100
Study: 18552710

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis Bb12 (probiotic)
Number of subjects: 69
Study: 15678547

Group type: EXPERIMENTAL
Intervention: Multiple sclerosis patients (MS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 76